<DOC>
	<DOCNO>NCT01139905</DOCNO>
	<brief_summary>To study pharmacokinetics low-dose lopinavir/ritonavir tablet HIV-1 infect Thai child .</brief_summary>
	<brief_title>Lopinavir/Ritonavir ( LPV/r ) Tablet HIV Infected Children</brief_title>
	<detailed_description>This open-label , single arm study compare standard dose new tablet formulation lower dose lopinavir/ritonavir HIV-1 infected child .</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>1 . HIV infection 2 . Age &lt; 18 year old 3 . BW &gt; 25 kg 4 . HIV RNA viral load &lt; 50 copy within 6 month 5 . Written inform consent 1 . Active opportunistic infection 2 . Relevant history current condition , illness might interfere drug absorption , distribution , metabolism excretion . 3 . Use concomitant medication may interfere pharmacokinetics lopinavir/ritonavir</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Lopinavir/ritonavir</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>low dose</keyword>
	<keyword>HIV-infected child</keyword>
	<keyword>pharmacokinetics low-dose lopinavir/ritonavir HIV-1 infect Thai child .</keyword>
</DOC>